Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novamind Inc. NVMDF

Healthcare Biotechnology
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.


OTCQB:NVMDF - Post by User

Novamind Inc. > Swindled
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(41)
•••
Comment by yvreanon Jun 15, 2022 1:39pm
53 Views
Post# 34758679

RE:Swindled

RE:SwindledNovamind shares are now Numinus and Numinus shares keep loosing value and Novamind shareholders cannot make trades to get out of this holding because Numinus could not be bothered to make this share swap available for the 13th. What bothers me more than all of this is there is no other shareholder voicing their concern other than me. Is everyone too stoned to care? Perhaps the SEC would like to investigate this transaction, because that major single person at Novamind who made this deal has his money, but no other shareholders can make trades???????
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities